We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6857:TSEAdvantest Corp. Analysis

Data as of 2026-06-14 - not real-time

¥27,325.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Advantest currently trades at ¥27,325, above its 20‑day (¥26,401) and 50‑day (¥26,517) SMAs, indicating short‑term price strength, but the MACD line sits below the signal line (‑211 vs ‑146) and the histogram is negative, flagging bearish momentum. The RSI at 52.9 suggests a neutral over‑/under‑bought condition. Volatility is elevated at 65% over the past 30 days and beta exceeds 1.5, pointing to heightened price swings relative to the market. Fundamentally, the company reports robust 41% revenue growth, a 64% gross margin and a 33% profit margin, with ROE of 57.6% and ample cash of ¥340 bn versus ¥20 bn debt. However, the trailing P/E of 53 is well above the industry average of 36.8 and the DCF‑derived fair value of ¥12,476 is less than half the current price, marking the stock as overvalued.
Recent news reinforces Advantest’s market position – it secured the #1 spot in the 2026 TechInsights Customer Satisfaction Survey for the seventh year and announced a strategic partnership with Applied Materials’s EPIC platform, expanding its ecosystem reach. New product rollouts such as the Pin Scale 5000B and Velocity™ automation showcase continued innovation. Despite a modest 0.22% dividend yield and a low 11.5% payout ratio, the high valuation and bearish technical signals temper short‑term upside, while the strong earnings profile and growth initiatives support a more positive medium‑term outlook. Investors should weigh the premium pricing against the company’s growth trajectory and sector cyclicality.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram
  • Current price above SMAs but overvalued relative to DCF
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • 41% revenue growth and strong margins
  • Top ranking in customer satisfaction and new partnership with Applied Materials
  • Robust cash position supporting continued R&D

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustained high ROE and cash generation
  • Persistent sector cyclicality and valuation premium
  • Low dividend payout sustaining financial flexibility

Key Metrics & Analysis

Financial Health

Revenue Growth41.20%
Profit Margin33.26%
P/E Ratio53.2
ROE57.65%
ROA30.79%
Debt/Equity2.54
P/B Ratio24.9
Op. Cash Flow¥335.2B
Free Cash Flow¥240.9B
Industry P/E36.8

Technical Analysis

TrendNeutral
RSI52.9
Support¥24,150.00
Resistance¥28,515.00
MA 20¥26,400.75
MA 50¥26,516.80
MA 200¥21,485.60
MACDBearish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value¥12,475.80
Target Price¥33,220.00
Upside/Downside21.57%
GradeOvervalued
TypeGrowth
Dividend Yield0.22%

Risk Assessment

Beta1.66
Volatility65.44%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.